News
QA Director Nancy Boxx Weighs In On FDA Draft Guidance On Use of Natural History Studies
In March, The FDA released a draft guidance on the use of natural history studies in rare disease clinical trials. […]
April 22, 2019
CIS Annual Meeting 2019 in Atlanta: International Presence, PID, IVIG, and a Popular Booth
ARG Project Manager Amber Schroeder and Clinical Research Associate Corina Moorehead attended the CIS Annual Meeting in Atlanta April 4-7. […]
April 10, 2019
ARG Conference News: CIS 2019 Annual Meeting in Atlanta
Two ARG team members will be attending the CIS Annual Meeting in Atlanta April 4-7. ARG has deep experience in […]
March 15, 2019
QA Director Nancy Boxx Comments on New FDA Guidances in Cancer Trials
Nancy Boxx, ARG Director of Quality Assurance, has provided comments for a piece on Outsourcing-Pharma.com that addresses the new FDA […]
March 15, 2019
SCOPE: Patient Centricity, Diversity, AI, Risk-Based Monitoring & Outsourcing Strategy
ARG Vice-President of Corporate Development Shay Brill and Senior Project Manager Brad Whitlow attended the 10th annual SCOPE Summit February […]
February 26, 2019
CTO Hunter Walker Sits For A Video Interview with Veeva
Chief Technology Officer Hunter Walker sat for an interview to discuss the ARG-Veeva partnership in September, 2018. Filmed in Philadelphia, […]
February 20, 2019